key: cord-0691118-uwyamqa2
authors: Neoptolemos, J P; Greenhalf, W
title: Linking COVID-19 and Acute Pancreatitis Through the Pathogenic Effects of the SARS-CoV-2 S Protein Subunit 1 on Pancreatic Stellate Cells and Macrophages
date: 2022-02-26
journal: Function (Oxf)
DOI: 10.1093/function/zqac009
sha: aecc6d629b9ac9804450e44992b98dab7980e4a3
doc_id: 691118
cord_uid: uwyamqa2

nan

Since the early 1970's Ole Peterson has been at the forefront of many of the major scientific discoveries that have moulded our understanding of pancreatic acinar cell physiology and of the pathophysiology leading to acinar cell necrosis and acute pancreatitis. 1 Pulse chase studies in the 1970s identified exocytosis as the key secretory pathway in pancreatic acini, occurring in response to physiologic concentrations of cholecystokinin or acetylcholine. This process involves the transport of proteins from the endoplasmic reticulum to the Golgi complex, concentration within condensing vacuoles and zymogen granules, and release into the extra-acinar lumen at the apical plasma membrane. Subsequent studies showed that supramaximal secretagogue stimulation resulted in blockade of apical exocytosis and release of intracellular granules from the baso-lateral plasma membrane into the intercellular space.

This was shown to be a key pathogenic mechanism in the early evolutionary stages of acute pancreatitis. Normal exocytosis is governed by local cytosolic Ca 2+ spikes in the granular apical region. The Ca 2+ is released from intracellular stores in the endoplasmic reticulum via inositol trisphosphate and ryanodine receptors, and acid stores via the two-pore channel and ryanodine receptors. Apical cytosol Ca 2+ spiking also causes increased mitochondrial ATP production, to provide the energy source driving the mechanism of exocytosis. 1 Pathogenic signals including fatty acids, alcohol, bile acids, and physical pressure result in sustained cytosolic Ca 2+ overloading. The consequences are direct trypsinogen activation within the zymogen granules with intra-cytosolic release of trypsin, as well as release into the intercellular space. There is also mitochondrial Ca 2+ overload with reduced ATP formation.

These processes combine to produce acinar cell necrosis and an ever-expanding surrounding focus of tissue destruction. This is amplified by activation of both pancreatic stellate cells (by released kallikrein converted to bradykinin acting on the B2 receptor) generating toxic nitric

oxide levels, and activation of resident macrophages (by released ADP and ATP acting on purinergic receptors) generating a series of cytokines including tumour necrosis factor-α.

These processes result in further recruitment of circulating inflammatory cells into the foci of developing pancreatic necrosis. In clinically severe acute pancreatitis, the excessive inflammatory cell activation triggers an uncontrolled systemic anti-inflammatory response leading to multi-organ failure, especially affecting the lungs and kidneys.

In this latest work produced by Ole Petersen along with his longstanding co-workers Julia and Oleg Gerasimenko we are shown new insights into the pathogenic effects of the SARS-CoV-2 on pancreatic lobular cells. 2 The link between SARS-CoV-2 and pancreatitis was identified very early on in the COVID-19 pandemic but it's true significance remains unclear. 3 The nature of the link remains contentious, with some groups suggesting that the viral infection was not directly linked to the pancreatitis and even that many cases of pancreatitis were spurious since the raised amylase seen in patients with COVID-19 was SARS-CoV-2 tropism towards distinct tissues is governed by cellular factors expressed on target cells. Viral entry requires attachment of the spike protein to angiotensin-converting enzyme 2 (ACE2). 6 The transmembrane serine protease 2 (TMPRSS2) is also required for cleavage of sites S1 and S2 for membrane fusion and receptor mediated endocytosis. 6 ACE2 and TMPRSS2 have both been identified in pancreatic endothelial pericytes and also in pancreatic ductal cells. 7, 8 Expression of ACE2 and TMPRSS2 in human acini have also been found but this seems to be at low levels and patchy in distribution. 7, 8 Genetic variants of TMPRSS2 may account for differential susceptibility to SARS-CoV-2 infection and COVID-19 disease severity. 9 SARS-CoV-2 is also able to cause diffuse severe endothelial inflammation, and microvascular thrombosis in several anatomical sites, leading to diffuse microischaemia, an established cause of acute pancreatitis. 10 perhaps giving a mechanism to explain reports of acute pancreatitis following vaccination. 

The roles of calcium and ATP in the physiology and pathology of the exocrine pancreas

SARS-CoV-2 S Protein Subunit 1 Elicits Ca2+ Influx -Dependent Ca2+ Signals in Pancreatic Stellate Cells and Macrophages In Situ

Pancreatic Injury Patterns in Patients With Coronavirus Disease 19 Pneumonia

COVID-19 and acute pancreatitis: examining the causality

SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in beta Cells

SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas

A common TMPRSS2 variant has a protective effect against severe COVID-19

The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection